Pancreatic Cancer Research

ResearcherJiangsu Province HospitalActive in the last 2 years

Rui Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5116-4193; OpenAlex author ID A5101802584. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Formin protein DAAM1 positively regulates PD-L1 expression via mediating the JAK1/STAT1 axis in pancreatic cancer. Co-author DOI 10.1186/s12935-024-03631-8↗
  2. NEUROD1 predicts better prognosis in pancreatic cancer revealed by a TILs-based prognostic signature. Co-author DOI 10.3389/fphar.2022.1025921↗
  3. Profiles and clinical significance of immune cell infiltration in pancreatic adenocarcinoma First author DOI 10.1101/2020.03.30.017327↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jie Mei · 3 shared papers, 2020–2025 · strength 0.54
  2. Chaoying Liu · 2 shared papers, 2020–2022 · strength 0.28
  3. Jiayue Yang · 1 shared paper, 2025 · strength 0.26
  4. Jing Yi Sun · 1 shared paper, 2025 · strength 0.26
  5. Zhiyang Jiang · 1 shared paper, 2022 · strength 0.15
  6. Junli Ding · 1 shared paper, 2022 · strength 0.15
  7. Junying Xu · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.